It will be interesting to evaluate what fraction of patients with migraine, with or without anxiety, sleep, or memory disorders, harbor low frequency or rare variants in CNR1. Similarly, the prevalence of rare DAGLA variants in patients with developmental disorders should be investigated. The gene discussed is CNR1; the disease is Anxiety.